Literature DB >> 27587988

Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Dmitriy M Niyazov1, Stephan G Kahler2, Richard E Frye2.   

Abstract

Mitochondrial disease refers to a heterogeneous group of disorders resulting in defective cellular energy production due to abnormal oxidative phosphorylation (oxphos). Primary mitochondrial disease (PMD) is diagnosed clinically and ideally, but not always, confirmed by a known or indisputably pathogenic mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) mutation. The PMD genes either encode oxphos proteins directly or they affect oxphos function by impacting production of the complex machinery needed to run the oxphos process. However, many disorders have the 'mitochondrial' phenotype without an identifiable mtDNA or nDNA mutation or they have a variant of unknown clinical significance. Secondary mitochondrial dysfunction (SMD) can be caused by genes encoding neither function nor production of the oxphos proteins and accompanies many hereditary non-mitochondrial diseases. SMD may also be due to nongenetic causes such as environmental factors. In our practice, we see many patients with clinical signs of mitochondrial dysfunction based on phenotype, biomarkers, imaging, muscle biopsy, or negative/equivocal mtDNA or nDNA test results. In these cases, it is often tempting to assign a patient's phenotype to 'mitochondrial disease', but SMD is often challenging to distinguish from PMD. Fortunately, rapid advances in molecular testing, made possible by next generation sequencing, have been effective at least in some cases in establishing accurate diagnoses to distinguish between PMD and SMD. This is important, since their treatments and prognoses can be quite different. However, even in the absence of the ability to distinguish between PMD and SMD, treating SMD with standard treatments for PMD can be effective. We review the latest findings regarding mitochondrial disease/dysfunction and give representative examples in which differentiation between PMD and SMD has been crucial for diagnosis and treatment.

Entities:  

Keywords:  Mitochondria; Mitochondrial DNA; Non-mitochondrial disorder; Nuclear DNA; Primary mitochondrial disease; Secondary mitochondrial dysfunction

Year:  2016        PMID: 27587988      PMCID: PMC4988248          DOI: 10.1159/000446586

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  130 in total

Review 1.  Mitochondrial diseases.

Authors:  Tuan H Vu; Michio Hirano; Salvatore DiMauro
Journal:  Neurol Clin       Date:  2002-08       Impact factor: 3.806

2.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

3.  Mitochondrial disease in 22q13 duplication syndrome.

Authors:  Richard E Frye
Journal:  J Child Neurol       Date:  2012-02-28       Impact factor: 1.987

Review 4.  Mitochondrial dysfunction in neuromuscular disorders.

Authors:  Christos D Katsetos; Sirma Koutzaki; Joseph J Melvin
Journal:  Semin Pediatr Neurol       Date:  2013-11-05       Impact factor: 1.636

5.  Immune mediated conditions in autism spectrum disorders.

Authors:  Ousseny Zerbo; Albin Leong; Lisa Barcellos; Pilar Bernal; Bruce Fireman; Lisa A Croen
Journal:  Brain Behav Immun       Date:  2015-02-11       Impact factor: 7.217

6.  Mitochondrial dysfunction in autism.

Authors:  Cecilia Giulivi; Yi-Fan Zhang; Alicja Omanska-Klusek; Catherine Ross-Inta; Sarah Wong; Irva Hertz-Picciotto; Flora Tassone; Isaac N Pessah
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

7.  Mitochondrial Dysfunction in a Patient with 8q21.11 Deletion and Charcot-Marie-Tooth Disease Type 2K due to GDAP1 Haploinsufficiency.

Authors:  Dmitriy Niyazov; Diane Africk
Journal:  Mol Syndromol       Date:  2015-09-18

Review 8.  Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology.

Authors:  Ming Zhan; Craig Brooks; Fuyou Liu; Lin Sun; Zheng Dong
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

9.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.

Authors:  Richard E Frye; Devin Cox; John Slattery; Marie Tippett; Stephen Kahler; Doreen Granpeesheh; Shirish Damle; Agustin Legido; Michael J Goldenthal
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

10.  Apoptosis and necrosis mediate skeletal muscle fiber loss in age-induced mitochondrial enzymatic abnormalities.

Authors:  Nashwa Cheema; Allen Herbst; Debbie McKenzie; Judd M Aiken
Journal:  Aging Cell       Date:  2015-09-14       Impact factor: 9.304

View more
  61 in total

Review 1.  NDUFS6 related Leigh syndrome: a case report and review of the literature.

Authors:  Cécile Rouzier; Annabelle Chaussenot; Konstantina Fragaki; Valérie Serre; Samira Ait-El-Mkadem; Christian Richelme; Véronique Paquis-Flucklinger; Sylvie Bannwarth
Journal:  J Hum Genet       Date:  2019-04-04       Impact factor: 3.172

Review 2.  Tying trafficking to fusion and fission at the mighty mitochondria.

Authors:  Trey Farmer; Naava Naslavsky; Steve Caplan
Journal:  Traffic       Date:  2018-05-11       Impact factor: 6.215

3.  Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project.

Authors:  Amel Karaa; Shamima Rahman; Anne Lombès; Patrick Yu-Wai-Man; Muniza K Sheikh; Sherita Alai-Hansen; Bruce H Cohen; David Dimmock; Lisa Emrick; Marni J Falk; Shana McCormack; David Mirsky; Tony Moore; Sumit Parikh; John Shoffner; Tanja Taivassalo; Mark Tarnopolsky; Ingrid Tein; Joanne C Odenkirchen; Amy Goldstein
Journal:  J Inherit Metab Dis       Date:  2017-03-16       Impact factor: 4.982

Review 4.  Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage.

Authors:  Yu-Hang Jiang; Jia-Kai He; Ran Li; Ze-Hao Chen; Bao-Hui Jia
Journal:  Chin J Integr Med       Date:  2022-03-01       Impact factor: 1.978

Review 5.  Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis.

Authors:  Ian W Weidling; Russell H Swerdlow
Journal:  Exp Neurol       Date:  2020-04-25       Impact factor: 5.330

6.  Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.

Authors:  Sujay Guha; Chigoziri Konkwo; Manuela Lavorato; Neal D Mathew; Min Peng; Julian Ostrovsky; Young-Joon Kwon; Erzsebet Polyak; Richard Lightfoot; Christoph Seiler; Rui Xiao; Michael Bennett; Zhe Zhang; Eiko Nakamaru-Ogiso; Marni J Falk
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

Review 7.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

Review 8.  Advancing human disease research with fish evolutionary mutant models.

Authors:  Emily A Beck; Hope M Healey; Clayton M Small; Mark C Currey; Thomas Desvignes; William A Cresko; John H Postlethwait
Journal:  Trends Genet       Date:  2021-07-29       Impact factor: 11.639

9.  Bi-allelic variants in MTMR5/SBF1 cause Charcot-Marie-Tooth type 4B3 featuring mitochondrial dysfunction.

Authors:  Beatrice Berti; Giovanna Longo; Francesco Mari; Stefano Doccini; Ilaria Piccolo; Maria Alice Donati; Francesca Moro; Renzo Guerrini; Filippo M Santorelli; Vittoria Petruzzella
Journal:  BMC Med Genomics       Date:  2021-06-12       Impact factor: 3.063

Review 10.  Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

Authors:  Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.